Skip to content

Engineering a whole-cell catalyst for enhanced production of 2,5-bis(hydroxymethyl)furan and comparative cellular responses to deep eutectic solvents.

Nov 2026 · Bioresource Technology · pp. 136186 · 0 citations · 59 references
Medicine

Abstract

Biocatalytic reduction of 5-hydroxymethylfurfural (HMF) to 2,5-bis(hydroxymethyl)furan (BHMF) is a key step in biomass valorization; however, the intrinsic toxicity of HMF at high concentrations often limits catalytic efficiency. Here, we identified a novel short-chain dehydrogenase/reductase, HetN, from our previously reported Enterobacter ludwigii YYP3 and engineered an improved variant, T140Q/V39H, by targeting the HMF- and NADPH-binding pockets. The resulting Escherichia coli whole-cell catalyst completely converted 200 mM HMF to BHMF within 1.8 h, achieving a high space-time yield of 14.2 g·L-1·h-1 and maintaining high catalytic performance over 20 reuse cycles. Structural and kinetic analyses suggested that the enhanced activity was associated with additional interactions of T140Q with HMF and V39H with NADPH, thereby favoring substrate binding. Preparative-scale production was successfully demonstrated, and an improved downstream separation strategy was developed to obtain highly pure solid BHMF. A rapid 0.5-h one-pot chemo-biocatalytic cascade from d-fructose to BHMF was further established in the deep eutectic solvent (DES) Bet:BSA, achieving an overall BHMF molar yield of 56%. Comparative analysis of different DESs revealed shared and DES-specific cellular and metabolic perturbations associated with impaired whole-cell catalytic performance. Overall, this study provides an efficient HetN-based whole-cell catalyst for BHMF production and advances the understanding of cellular responses to DES exposure.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.